BioChain BioChain Threatens Legal Action Against Epigenomics for Contract Termination Epigenomics terminated a licensing contract related to Chinese distribution rights for its Septin9 biomarker and Epi proColon colorectal cancer blood test. Epigenomics, BioChain Ink Lung Cancer Dx Deal in China The deal covers a panel of blood-based DNA methylation biomarkers derived in part from Epigenomics' bronchoalveolar lavage-based Epi proLung BL test. UPDATE: BioChain to Supply FFPE Samples to ArcherDx The samples, which include non-small cell lung cancer samples, will be screened for cancer fusions, copy number variations, SNPs, and insertions and deletions. Epigenomics' Epi proColon Test Included in China's Colorectal Cancer Screening Guideline The Chinese guideline recommends the use of the Septin-9 DNA methylation assay as the standard of care for early colorectal cancer screening. Breaking News Agilent Technologies Fiscal Q2 Revenues Rise 5 Percent SARS-CoV-2 Genome Analysis Reveals Fitness-Enhancing Mutations Startup Incubator IndieBio, GP-Write Launch Initiative to Fund Genome Engineering Firms Precipio Receives CE-IVD Mark for Hematologic Cancer Panels Illumina Adds CDx Indication to European TruSight Oncology Test for NTRK Gene Fusion Detection BioMérieux Gets Health Canada Approval for Updated BioFire Blood Culture ID Panel The Scan Taking Stock of the Stockpile The US and European countries are evaluating their smallpox vaccine stockpiles as the number of monkeypox cases increases, the Washington Post reports. Vitamin D From Tomatoes According to Reuters, researchers in the UK have gene-edited tomatoes so their fruit contains vitamin D. Cause Not Yet Spotted NPR reports that a new study was unable to find a cause for persistent long COVID symptoms. PNAS Papers on Central African Hunter-Gatherers, Myopia Development, Ancient Microtia Allele In PNAS this week: population patterns among Central African hunter gatherers, effect of myopia-linked gene variant, and more.